Indeed, different CSCs-centered anti-cancer strategies have been assessed that foresee the targeting CSCs specific surface markers and tumor microenvironment, the inhibition of ATP-binding cassette transporters, the switching off CSCs self-renewal and survival signaling pathways and immunotherapy (133, 134). The gene discussed is ABCA4; the disease is neoplasm.